Stabilization of peptide guinea pig myelin basic protein 72-85 by N-terminal acetylation - Implications for immunological studies

Molecular Immunology

Volumn 40, Issue 13, 2004, Pages 943-948

  De Haan, Ellen C ^a   Wauben, Marca H M ^b   Wagenaar Hilbers, Josée P A ^b   Grosfeld Stulemeyer, Mayken C ^b   Rijkers, Dirk T S ^a   Moret, Ed E ^a   Liskamp, Rob M J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Acetylation; Experimental autoimmune encephalomyelitis, EAE; Major histocompatibility complex, MHC; Myelin basic protein, MBP; Peptide; Pyroglutamic acid

Indexed keywords

AMINO ACID; GLUTAMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PEPTIDE DERIVATIVE; PYROGLUTAMIC ACID;

ACETYLATION; ALLERGIC ENCEPHALOMYELITIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYCLIZATION; GUINEA PIG; IMMUNOCOMPETENT CELL; IMMUNOLOGY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; QUALITY CONTROL; RAT; T LYMPHOCYTE;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0347915528     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2003.10.015     Document Type: Article

References (36)

1. Allen, G., 1981. Sequencing of proteins and peptides. In: Work T.S., Burdon R.H. (Eds.), Laboratory techniques in biochemistry and molecular biology. Elsevier, Amsterdam, pp. 245-250.
2. Arnold P.Y., La Gruta N.L., Miller T., Vignali K.M., Adams P.S., Woodland D.L., Vignali D.A.A. The majority of immunogenic epitopes generate CD4(+) T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169:2002;739-749.
3. Beck A., Bussat M.-C., Klinguer-Hamour C., Goetsch L., Aubry J.-P., Champion T., Julien E., Haeuw J.F., Bonnefoy J.Y., Corvaia N. Stability and CTL activity of N-terminal glutamic acid containing peptides. J. Pept. Res. 57:2001a;528-538.
4. Beck H., Schwarz G., Schröter C.J., Deeg M., Baier D., Stevanovic S., Weber E., Driessen C., Kalbacher H. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur. J. Immunol. 31:2001;3726-3736.
5. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:1981;195-199.
6. Brinckerhoff L.H., Kalashnikov V.V., Thompson L.W., Yamshchikov G.V., Pierce R.A., Galavotti H.S., Engelhard V.H., Slingluff C.L. Jr. Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines. Int. J. Cancer. 83:1999;326-334.
7. Busby W.H. Jr., Quackenbush G.E., Humm J., Youngblood W.W., Kizer J.S. An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. J. Biol. Chem. 262:1987;8532-8536.
8. Chantry A., Gregson N., Glynn P. Degradation of myelin basic protein by a membrane-associated metalloprotease: neural distribution of the enzyme. Neurochem. Res. 17:1992;861-867.
9. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:1992;764-768.
10. Chou C.H.J., Chou F.C.H., Kowalski T.J., Shapira R., Kibler R.F. The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats. J. Neurochem. 28:1977;115-119.
11. Chou C.H.J., Fritz R.B., Chou F.C.H., Kibler R.F. The immune response of Lewis rats to peptide 68-88 of guinea pig myelin basic protein. I. T cell determinants. J. Immunol. 123:1979;1540-1543.
12. Chou Y.K., Vandenbark A.A., Jones R.E., Hashim G., Offner H. Selection of encephalitogenic rat T-lymphocyte clones recognizing an immunodominant epitope on myelin basic protein. J. Neurosci. Res. 22:1989;181-187.
13. de Haan E.C., Wauben M.H.M., Grosfeld-Stulemeyer M.C., Moret E.E. Structure-based design and evaluation of MHC class II binding peptides. Biologicals. 29:2001;289-292.
14. Dong X., An B., Salvucci Kierstead L., Storkus W.J., Amoscato A.A., Salter R.D. Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells. J. Immunol. 164:2000;129-135.
15. Elliott S.L., Pye S., Le T., Mateo L., Cox J., Macdonald L., Scalzo A.A., Forbes C.A., Suhrbier A. Peptide based cytotoxic T-cell vaccines delivery of multiple epitopes, help, memory and problems. Vaccine. 17:1999;2009-2019.
16. Groome N., Chantry A., Earl C., Newcombe J., Keen J., Findlay J., Glynn P. A new epitope on human myelin basic protein arising from cleavage by a metalloendoprotease associated with brain myelin membranes. J. Neuroimmunol. 19:1988;77-88.
17. He X.L., Radu C., Sidney J., Sette A., Ward E.S., Garcia K.C. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity. 17:2002;83-94.
18. Hunt D.F., Michel H., Dickinson T.A., Shabanowitz J., Cox A.L., Sakaguchi K., Appella E., Grey H.M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 256:1992;1817-1820.
19. Jardetzky T.S., Brown J.H., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl. Acad. Sci. U.S.A. 93:1996;734-738.
20. Joosten I., Wauben M.H.M., Holewijn M.C., Reske K., Pedersen L.O., Roosenboom C.F.P., Hensen E.J., van Eden W., Buus S. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules. Int. Immunol. 6:1994;751-759.
21. Lennon-Duménil A.-M., Bakker A.H., Wolf-Bryant P., Ploegh H.L., Lagaudrière-Gesbert C. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr. Opin. Immunol. 14:2002;15-21.
22. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622.
23. Maillère B., Hervé M. The specificity of antibodies raised against a T cell peptide is influenced by peptide amidation. Mol. Immunol. 34:1997;1003-1009.
24. Maillère B., Mourier G., Hervé M., Ménez A. Fine chemical modifications at N- and C-termini enhance peptide presentation to T cells by increasing the lifespan of both free and MHC-complexed peptides. Mol. Immunol. 32:1995;1377-1385.
25. Martenson R.E., Nomura K., Levine S., Sowinski R. Experimental allergic encephalomyelitis in the Lewis rat: farther delineation of active sites in guinea pig and bovine myelin basic proteins. J. Immunol. 118:1977;1280-1285.
26. Moscarello M.A., Pang H., Pace-Asciak C.R., Wood D.D. The N terminus of human myelin basic protein consists of C2, C4, C6, and C8 alkyl carboxylic acids. J. Biol. Chem. 267:1992;9779-9782.
27. Nelson C.A., Petzold S.J., Unanue E.R. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1227-1231.
28. Riese R.J., Chapman H.A. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12:2000;107-113.
29. Rijkers D.T.S., Höppener J.W.M., Posthuma G., Lips C.J.M., Liskamp R.M.J. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides. Chem.-Eur. J. 8:2002;4285-4291.
30. Rudensky A.Y., Preston-Hurlburt P., Hong S.C., Barlow A., Janeway C.A. Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature. 353:1991;622-627.
31. Stepaniak J.A., Gould K.E., Swanborg R.H. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog. J. Neurosci. Res. 45:1996;447-454.
32. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:1997;821-850.
33. Watts C. Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13:2001;26-31.
34. Wauben M.H.M., van der Kraan M., Grosfeld-Stulemeyer M.C., Joosten I. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule. Int. Immunol. 9:1997;281-290.
35. Wolf Bryant P., Lennon-Duménil A.M., Fiebiger E., Lagaudrière-Gesbert C., Ploegh H.L. Proteolysis and antigen presentation by MHC class II molecules. Adv. Immunol. 80:2002;71-114.
36. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 324:1986;258-260.